Dr. Ahmad Hanif, MD

Dr. Hanif practices at Geisinger Wyoming Valley Medical Center in Plains Township, Pennsylvania.

Dr. Hanif's NPI, 1316241870, was assigned on December 27, 2010. Dr. Hanif holds Pennsylvania license MD476726.

Dr. Hanif's primary practice is Geisinger Wyoming Valley Medical Center, at 1000 E Mountain Dr, Plains Township, PA 18702 in Luzerne County. The practice phone is (570) 826-7300.

Dr. Hanif's primary practice is Geisinger Wyoming Valley Medical Center in Plains Township, Pennsylvania. Dr. Hanif is also affiliated with Geisinger Wyoming Valley Medical Center. The medical group on file is Geisinger. Dmand AI also links Dr. Hanif to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hanif practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hanif's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Hanif's licenses on file in 3 states: Pennsylvania, New York and Wisconsin.

CMS data shows 619 Medicare services from Dr. Hanif across 6 procedure codes in 2024, for 237 Medicare patients. Medicare paid $35,000 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 237 Medicare patients who saw Dr. Hanif in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hanif's median patient age at 73, with 55% women.

In 2024, Dr. Hanif wrote 1,071 Medicare Part D claims for 233 patients. 76% of them were for generic drugs. CMS names the drug for 787 of them, across 27 drugs with 11 or more claims each, at $1,643,287 in total drug cost. In 2023, CMS named 515 claims across 22 drugs.

Dr. Hanif accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hanif as offering telehealth.

Dmand AI links 26 papers to Dr. Hanif, published from 2011 to 2025. 2017 was the busiest year, with 4. The most frequent topics are Epoxide Hydrolases, Hyperemia and Oxylipins. Dr. Hanif has published most often in Mol Cell Biochem. Dr. Hanif's most frequent co-authors are Muhammad Adrish, MD, Sumera Khan, MD, MS and Stephen L. Tilley, MD.

CMS Open Payments shows 96 general payments to Dr. Hanif from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Janssen Pharmaceuticals, Inc paid the most, $529.